Intestinal epithelial cells contain a high molecular weight protease subject to inhibition by anticarcinogenic protease inhibitors
- PMID: 1562990
- DOI: 10.1016/0304-3835(92)90063-2
Intestinal epithelial cells contain a high molecular weight protease subject to inhibition by anticarcinogenic protease inhibitors
Abstract
Protease inhibitors have been shown to be highly effective suppressors of carcinogenesis in both in vivo and in vitro model systems. For example, the soybean derived Bowman Birk inhibitor (BBI) has been shown to inhibit colon carcinogenesis. Although the precise mechanisms by which protease inhibitors suppress carcinogenesis are not known, it is believed that these compounds exert their anticarcinogenic effects by inhibiting specific cellular protease activities involved in the induction and/or expression of the transformed phenotype. In the current report, we describe a BBI-inhibitable proteolytic activity present in intestinal epithelial cells. The protease has a mass of approximately 125 kDa, cleaves gelatin and will bind to a BBI-affinity resin. Subcellular fractionation experiments indicate that this protease is located in the 10,000 x g pellet (lysosomal/golgi fraction) of IEC17 cell homogenates. Further studies have revealed that this proteolytic activity is inhibited by BBI and DFP, but unaffected by EDTA, indicating that this enzyme is a serine protease. Our results suggest that the 125-kDa protease is a 'target enzyme' of the BBI in these cells.
Similar articles
-
A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor.Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3120-4. doi: 10.1073/pnas.89.7.3120. Proc Natl Acad Sci U S A. 1992. PMID: 1557421 Free PMC article.
-
Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells.Eur J Cancer. 1991;27(7):903-8. doi: 10.1016/0277-5379(91)90144-3. Eur J Cancer. 1991. PMID: 1834126
-
A proteolytic activity in a human breast cancer cell line which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor.Cancer Lett. 1994 Oct 14;85(2):205-10. doi: 10.1016/0304-3835(94)90276-3. Cancer Lett. 1994. PMID: 7954338
-
Proteases, protease inhibitors and radiation carcinogenesis.Int J Radiat Biol. 2023;99(6):882-890. doi: 10.1080/09553002.2021.1962567. Epub 2021 Aug 10. Int J Radiat Biol. 2023. PMID: 34325613 Review.
-
Prevention of carcinogenesis by protease inhibitors.Cancer Res. 1994 Apr 1;54(7 Suppl):1999s-2005s. Cancer Res. 1994. PMID: 8137328 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources